2023 annual financial data
Fulcrum Therapeutics 2023 Operating margin
Fulcrum Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -3,945.24%.
Operating income was -110,664,000 USD and net income was -97,335,000 USD.
Operating cash flow was -90,965,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,805,000 USD
- Operating income
- -110,664,000 USD
- Net income
- -97,335,000 USD
- Operating cash flow
- -90,965,000 USD